Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTRANSMUCOSALGeneric

FENTANYL CITRATE

FENTANYL CITRATE

Standard Dose
EQ 0.2MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 078907 (ANDA).

Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE Sponsor SPECGX LLC Submission history Latest submission status date: 2022-12-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview FENTANYL CITRATE is listed in Drugs@FDA under application 078907 (ANDA). Marketing status: Discontinued Active ingredient FENTANYL CITRATE Form and strength TROCHE/LOZENGE;TRANSMUCOSAL - EQ 0.2MG BASE Sponsor SPECGX LLC Submission history Latest submission status date: 2022-12-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: STANDARD
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.